These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

663 related items for PubMed ID: 9532467

  • 1. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
    Costello MF, Hughes GJ, Garrett DK, Hanjani A, Steigrad SJ.
    Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
    [Abstract] [Full Text] [Related]

  • 2. Leuprolide acetate for inducing ovulation in women undergoing ovarian stimulation.
    diDonato P, Nola VF, Pittman TV, Marr V, Stubbs C, Meldrum DR.
    J Reprod Med; 1995 Oct; 40(10):715-6. PubMed ID: 8551474
    [Abstract] [Full Text] [Related]

  • 3. Risk of repeated spontaneous luteinizing hormone surges in ovarian stimulation for in vitro fertilization.
    Nisker JA, Bloch CL, Tummon IS, Daniel SA, Yuzpe AA.
    J Reprod Med; 1993 Jun; 38(6):413-6. PubMed ID: 8331617
    [Abstract] [Full Text] [Related]

  • 4. Women with ovulatory dysfunction undergoing ovarian stimulation with clomiphene citrate for intrauterine insemination may benefit from administration of human chorionic gonadotropin.
    Vlahos NF, Coker L, Lawler C, Zhao Y, Bankowski B, Wallach EE.
    Fertil Steril; 2005 May; 83(5):1510-6. PubMed ID: 15866592
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. GnRH agonist. Increasing the pregnancy rate after combined treatment with hMG/hCG and direct intraperitoneal insemination.
    Minoura H, Takeuchi S, Shen X, Shibahara T, Futamura N, Toyoda N.
    J Reprod Med; 1999 Jan; 44(1):18-22. PubMed ID: 9987734
    [Abstract] [Full Text] [Related]

  • 8. [Application of ultra-short gonadotropin-releasing hormone agonist protocol in controlled ovarian hyperstimulation].
    Zhao X, Zhang L, Gong S.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):589-92. PubMed ID: 9642373
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A comparison of clomiphene/menotropins and D-Trp6-LH-RH/menotropins cycles of IVF-ET in the same patients.
    Ron-El R, Caspi E, Golan A, Nachum H, Herman A, Soffer Y, Weinraub Z.
    Int J Fertil; 1991 Oct; 36(3):157-61. PubMed ID: 1678370
    [Abstract] [Full Text] [Related]

  • 11. Does ovulation stimulation improve fertility in women with minimal/mild endometriosis after laser laparoscopy?
    Kemmann E, Ghazi D, Corsan G, Bohrer MK.
    Int J Fertil Menopausal Stud; 1993 Oct; 38(1):16-21. PubMed ID: 8485606
    [Abstract] [Full Text] [Related]

  • 12. Human chorionic gonadotropin administration is associated with high pregnancy rates during ovarian stimulation and timed intercourse or intrauterine insemination.
    Mitwally MF, Abdel-Razeq S, Casper RF.
    Reprod Biol Endocrinol; 2004 Jul 07; 2():55. PubMed ID: 15239837
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
    Barroso G, Menocal G, Felix H, Rojas-Ruiz JC, Arslan M, Oehninger S.
    Fertil Steril; 2006 Nov 07; 86(5):1428-31. PubMed ID: 16978619
    [Abstract] [Full Text] [Related]

  • 15. The prevalence and influence of luteinizing hormone surges in stimulated cycles combined with intrauterine insemination during a prospective cohort study.
    Cantineau AE, Cohlen BJ, Dutch IUI Study Group.
    Fertil Steril; 2007 Jul 07; 88(1):107-12. PubMed ID: 17445811
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a new surgical approach for the treatment of clomiphene citrate-resistant infertility in polycystic ovary syndrome: laparoscopic ovarian multi-needle intervention.
    Kaya H, Sezik M, Ozkaya O.
    J Minim Invasive Gynecol; 2005 Jul 07; 12(4):355-8. PubMed ID: 16036198
    [Abstract] [Full Text] [Related]

  • 17. Subtle progesterone rise in the single-dose gonadotropin-releasing hormone antagonist (cetrorelix) stimulation protocol in patients undergoing in vitro fertilization or intracytoplasmic sperm injection cycles.
    Seow KM, Lin YH, Huang LW, Hsieh BC, Huang SC, Chen CY, Chen PH, Tzeng CR, Hwang JL.
    Gynecol Endocrinol; 2007 Jun 07; 23(6):338-42. PubMed ID: 17616858
    [Abstract] [Full Text] [Related]

  • 18. Intrauterine insemination results in couples requiring extended semen transport time.
    Randall GW, Gantt PA.
    Int J Fertil Womens Med; 2007 Jun 07; 52(1):28-34. PubMed ID: 17987885
    [Abstract] [Full Text] [Related]

  • 19. Highly purified hMG versus recombinant FSH plus recombinant LH in intrauterine insemination cycles in women ≥35 years: a RCT.
    Moro F, Scarinci E, Palla C, Romani F, Familiari A, Tropea A, Leoncini E, Lanzone A, Apa R.
    Hum Reprod; 2015 Jan 07; 30(1):179-85. PubMed ID: 25398971
    [Abstract] [Full Text] [Related]

  • 20. Double vs. single intrauterine insemination per cycle: use in gonadotropin cycles and in diagnostic categories of ovulatory dysfunction and male factor infertility.
    Randall GW, Gantt PA.
    J Reprod Med; 2008 Mar 07; 53(3):196-202. PubMed ID: 18441725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.